Table 2.
Treatment characteristics for patients undergoing preoperative chemoradiotherapy for gastric adenocarcinoma (n = 48)
| Characteristic | No. | % |
|---|---|---|
| Concurrent chemotherapy | ||
| 5-FU or Capecitabine |
19 |
40 |
| 5-FU/Carboplatin/Paclitaxel |
11 |
23 |
| 5-FU/Cisplatin |
6 |
13 |
| 5-FU/Mitomycin C |
3 |
6 |
| 5-FU/Methotrexate |
1 |
2 |
| Cisplatin/Paclitaxel |
6 |
13 |
| Carboplatin/Paclitaxel |
2 |
4 |
| Surgical procedure | ||
| Total gastrectomy |
13 |
27 |
| Partial gastrectomy |
9 |
19 |
| Esophagogastrectomy | ||
| Transhiatal |
5 |
10 |
| Ivor-Lewis |
4 |
8 |
| Sweet |
3 |
6 |
| McKeown |
1 |
2 |
| Not specified |
1 |
2 |
| No surgical resection | 12 | 25 |